Journals / Eurasian Journal of Medicine / 2015 / Cilt: 47 - Sayı: 2

FGF-23 ve α-Klotho Gen Polimorfizminin Kronik Periton Diyalizi Hastalarında Kemik Metabolizma Belirteçleriyle İlişkisi

FGF-23, α-Klotho Gene Polymorphism and Their Relationship with the Markers of Bone Metabolism in Chronic Peritoneal Dialysis Patients

Pages
115–125
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We were unable toshow any correlation between KGP and any of the CKD-MBD param- eters measured in this study.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of the present study was to evaluate the varia- tions of some major bone metabolism markers with reference toklotho gene polymorphism (KGP) and bone mineral density (BMD)values in patients on chronic peritoneal dialysis (CPD).
📊
Key Findings & Data:Materials and Methods: In 51 CPD patients and 40 healthy persons,assays for intact parathormone (iPTH), fibroblast growth factor 23(FGF-23), osteoprotegerin (OPG), osteocalcin (OC), procollagen type- 1 N terminal propeptide (PINP), beta- crosslaps (beta CTx ), tartrateresistant acid phosphatase (TRAP5b), bone alkaline phosphatase(BAP), 1,25(OH)D3, and 25(OH)D3 and a-klotho gene mutations wereperformed.
💡
Conclusion & Impact:We were unable toshow any correlation between KGP and any of the CKD-MBD param- eters measured in this study.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of the present study was to evaluate the varia- tions of some major bone metabolism markers with reference toklotho gene polymorphism (KGP) and bone mineral density (BMD)values in patients on chronic peritoneal dialysis (CPD). Materials and Methods: In 51 CPD patients and 40 healthy persons,assays for intact parathormone (iPTH), fibroblast growth factor 23(FGF-23), osteoprotegerin (OPG), osteocalcin (OC), procollagen type- 1 N terminal propeptide (PINP), beta- crosslaps (beta CTx ), tartrateresistant acid phosphatase (TRAP5b), bone alkaline phosphatase(BAP), 1,25(OH)D3, and 25(OH)D3 and a-klotho gene mutations wereperformed. Results: In CPD patients, 1,25(OH)D3 and 25(OH)D3 deficiency rateswere 96% and 94% respectively. iPTH (249 pg/mL vs 39 pg/mL) andFGF-23 (1089 RU/mL vs 153 RU/mL), OPG, OC, PINP, beta CTx, TRAP5blevels were significantly higher in patients. iPTH levels and whole- body BMD values were negatively correlated in patients. The rate ofKGP was similar in all groups. Conclusion: In CPD patients, besides vitamin D deficiency, high lev- els of OPG, OC, PINP, beta CTx, TRAP5b were evident. Positive cor- relation between iPTH levels and BAP and PINP levels suggested adiagnostic value for those markers during the management of CKDMBD. On the other hand, high serum TRAP5b concentrations did notseem to be affected by neither calcitriol treatment nor the severity ofhyperparathyroidism. iPTH and FGF-23 levels and whole-body BMDvalues showed a significant negative correlation. We were unable toshow any correlation between KGP and any of the CKD-MBD param- eters measured in this study.

Özet

Amaç: Çalışmamızda kronik periton diyalizi (KPD) hastalarında klot- ho gen polimorfizmi (KGP) ve kemik mineral yoğunluğu (KMY) ilebazı major kemik metabolizma belirteçleri arasındaki ilişkinin araştırılması amaçlanmıştır. Gereç ve Yöntem: Çalışmaya dahil edilen 51 KPD hastası ve 40 sağlıklı kontrol grubunda intakt parathormon (iPTH), fibroblast büyümefaktör (FGF-23), osteoprotogerin (OPG), osteokalsin (OK), prokollajentip-1 N terminal propeptid (PINP), beta- crosslaps (beta KTx), tarta- rate resistan asid fosfataz (TRAF5b), kemik alkalen fosfataz (KAF),1,25(OH)D3, 25(OH)D3 ve a-klotho gen mutasyonları ölçüldü. Bulgular: 51 KPD hastasında 1,25(OH)D3 ve 25(OH)D3 eksikliği oranısırasıyla %96 ve %94 olarak tespit edildi. iPTH (249 pg/mL ve 39 pg/mL)ve FGF-23 (1089 RU/mL ve 153 RU/mL), OPG, OK, PINP, beta CTx, TRAP5bseviyeleri hastalarda istatistiksel olarak anlamlı derecede daha yüksekbulundu. Hastalarda iPTH seviyeleri ve tüm vücut KMY arasında negatifkorelasyon tespit edildi. KGP oranı gruplar arasında benzer bulundu. Sonuç: Kronik periton diyalizi hastalarında D vitamin eksikliğine ekolarak, OPG, OK, PINP, beta CTx, TRAP5b düzeyleri yüksek saptandı.iPTH seviyeleri ile KAF ve PINP arasındaki pozitif korelasyon bu belirteçlerin kronik böbrek hastalarındaki (KBH) kemik mineral hastalıklarının (KMH) tedavisinde tanısal değerinin olduğunu göstermiştir. Diğer taraftan yüksek serum TRAP5b konsantrasyonunun kalsitrioltedavisi ve hiperparatiroidinin şiddetinden etkilenmediği de gösterilmiştir. iPTH ve FGF-23 düzeyleri ile tüm vücut KMY arasında anlamlınegatif korelasyon tespit edilmiştir. Çalışmamızda klotho gen polimorfizmi ile KBH-KMHnın hiçbir belirteci arasında anlamlı korelasyon gösterilememiştir.

🔖

Cite This Article

DONMEZ, L., OZDEM, S., SULEYMANLAR, G., CETİNKAYA, R., ERSOY, F. F., YILMAZ, V. T. (2022). FGF-23 ve α-Klotho Gen Polimorfizminin Kronik Periton Diyalizi Hastalarında Kemik Metabolizma Belirteçleriyle İlişkisi. Eurasian Journal of Medicine, Cilt: 47 - Sayı: 2, 115–125. https://ajindex.com/articles/509099

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Gutiérrez OM, Mannstadt M, Isakova T, et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialy- sis. N Engl J Med 2008; 359: 584-92. [CrossRef] 2. Gutiérrez OM, Januzzi JL, Isakova T, et al. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 2009; 119: 2545-52. [CrossRef] 3. Huang CL. Regulation of ion channels by secreted Klotho: mecha- nisms and implications. Kidney Int 2010; 77: 855-60. [CrossRef] 4. Choi BH, Kim CG, Lim Y, Lee YH, Shin SY. Transcriptional activation of the human Klotho gene by epidermal growth factor in HEK293 cells; role of Egr-1. Gene 2010; 450: 121-7. [CrossRef] 5. Adij iang A, Niwa T. An oral sorbent, AST-120, increases Klotho expression and inhibits cell senescence in the kidney of uremic rats. Am J Nephrol 2010; 31: 160-4. [CrossRef] 6. Bostrom MA, Hicks PJ, Lu L, Langefeld CD, Freedman BI, Bowden DW. Association of polymorphisms in the klotho gene with severity of non-diabetic ESRD in African Americans. Nephrol Dial Transplant 2010; 25: 3348-55. [CrossRef] 7. Oguro R, Kamide K, Kokubo Y, et al. Association of carotid ath- erosclerosis with genetic polymorphisms of the klotho gene in patients with hypertension. Geriatr Gerontol Int 2010; 10: 311-8. [CrossRef] 8. Shimoyama Y, Taki K, Mitsuda Y, Tsuruta Y, Hamajima N, Niwa T. KLOTHO gene polymorphisms G-395A and C1818T are associated with low-density lipoprotein cholesterol and uric acid in Japanese hemodialysis patients. Am J Nephrol 2009; 30: 383-8. [CrossRef] 9. Kim Y, Jeong SJ, Lee HS, et al. Polymorphism in the promoter region of the klotho gene (G-395A) is associated with early dysfunction in vascular access in hemodialysis patients. Korean J Intern Med 2008; 23: 201-7. [CrossRef] 10. Kitazawa S, Kajimoto K, Kondo T, Kitazawa R. Vitamin D3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter. J Cell Biochem 2003; 89: 771-7. [CrossRef] 11. Johnson DW, McIntyre HD, Brown A, Freeman J, Rigby RJ. The role of DEXA bone densitometry in evaluating renal osteodys- trophy in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1996; 16: 34-40. 12. Baszko-Blaszyk D, Grzegorzewska AE, Horst-Sikorska W, Sowinski J. Bone mass in chronic renal insufficiency patients treated with continuous ambulatory peritoneal dialysis. Adv Perit Dial 2001; 17: 109-13. 13. Passadakis P, Thodis E, Manavis J, Mourvati E, Panagoutsos S, Vargemezis V. The identification o